On 4 and 5 September 2023, Sofia welcomed 62 participants from nearly 30 countries for the second Working Group and Management Committee meetings of the HAPLO-iPS COST Action CA21151 – Generation of Human Induced Pluripotent Stem Cells from Haplo-Selected Cord Blood Samples.
During the first day, the Action’s seven Working Groups met in parallel sessions to review progress, discuss scientific and organisational challenges and define priorities for the following Action period. The presentations and discussions provided an important opportunity for researchers and Working Group leaders to exchange experience and coordinate their joint activities.
The Management Committee met on 5 September to review the implementation of the Action and plan its next steps. The programme included updates on the Action’s membership, finances and leadership structure, as well as discussions on the COST Excellence and Inclusiveness policy, grant-awarding procedures, science communication and future activities.
By bringing together experts from across Europe and beyond, the Sofia meetings strengthened cooperation within the HAPLO-iPS network and supported its shared objective of advancing the development of HLA-homozygous human induced pluripotent stem-cell resources for future research and cell-therapy applications.
